| 0.0924 -0.005 (-4.74%) | 05-14 15:59 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 0.15 | 1-year : | 0.19 |
| Resists | First : | 0.13 | Second : | 0.16 |
| Pivot price | 0.1 |
|||
| Supports | First : | 0.07 | Second : | 0.06 |
| MAs | MA(5) : | 0.08  |
MA(20) : | 0.11 |
| MA(100) : | 0.23 |
MA(250) : | 0.7 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 21.5 |
D(3) : | 17 |
| RSI | RSI(14): 39.8 |
|||
| 52-week | High : | 3 | Low : | 0.07 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ WGRX ] has closed above bottom band by 33.0%. Bollinger Bands are 50.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 0.12 - 0.12 | 0.12 - 0.12 |
| Low: | 0.09 - 0.09 | 0.09 - 0.09 |
| Close: | 0.1 - 0.1 | 0.1 - 0.1 |
Wellgistics Health, Inc. operates as a wholesaler and distributor of pharmaceutical products to pharmaceutical manufacturers and independent retail pharmacies in the United States. The company distributes generic and branded pharmaceuticals, as well as over-the-counter healthcare and consumer products. It also offers third-party logistics services that include warehousing, inventory management, pick and pack, and shipping to small and mid-size pharmaceutical manufacturers. It also operates DelivMeds platform that serves as a pharmaceutical hub to facilitate the transfer of prescriptions and provide backend clinical concierge services to a network of independent pharmacies; and operates a retail community specialty. The company was formerly known as Danam Health, Inc. and changed its name to Wellgistics Health, Inc. in October 2024. Wellgistics Health, Inc. was incorporated in 2022 and is based in Tampa, Florida.
Thu, 14 May 2026
Wellgistics Health signs letter of intent to acquire WellCare Today By Investing.com - Investing.com Australia
Thu, 14 May 2026
Wellgistics targets smartwatch care firm WellCare Today in $15M LOI - Stock Titan
Wed, 13 May 2026
Pilot aims to tap 6,500 pharmacies for chronic care, remote monitoring - Stock Titan
Fri, 08 May 2026
Wellgistics Health Enters Forbearance Agreement to Manage Debt - The Globe and Mail
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Distribution
|
|
| Shares Out | 127 (M) |
| Shares Float | 46 (M) |
| Held by Insiders | 47.9 (%) |
| Held by Institutions | 1.5 (%) |
| Shares Short | 15,630 (K) |
| Shares Short P.Month | 6,270 (K) |
| EPS | -1.43 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -0.12 |
| Profit Margin | 0 % |
| Operating Margin | -766.1 % |
| Return on Assets (ttm) | -115.7 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | -86.5 % |
| Gross Profit (p.s.) | -0.06 |
| Sales Per Share | 0.18 |
| EBITDA (p.s.) | -0.62 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -11 (M) |
| Levered Free Cash Flow | 8 (M) |
| PE Ratio | -0.07 |
| PEG Ratio | 0 |
| Price to Book value | -0.78 |
| Price to Sales | 0.5 |
| Price to Cash Flow | -1.08 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|